Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

Healthcare Biotechnology
"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

TELESTA THERAPEUTICS INC
Bullboard Posts
User Avatar Image
(0)
•••
Post by toothpickon Oct 02, 2010 6:13pm
468 Views
Post# 17522109

Endo

EndoAccording to this article
https://technews.tmcnet.com/topics/associated-press/articles/105655-endo-pharma-paying-12-billion-qualitest.htm

latest Endo buyout - 1.2billion $ - will add about 400 million $ sales and 0.40$/share (net profit)

This is looking an expensive move to me.


Interresing article on Endo's model ("Virtual R&D") that mention.. "Our virtual R&D model allows us to expand beyond pain treatments to take on conditions in oncology, urology and more."

https://medhealth.tmcnet.com/topics/healthcare-leaders-care-points/articles/105184-endo-pharmaceuticals-embraces-virtual-rd-expand-drug-pipeline.htm
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities